Genetic Technologies Limited (NASDAQ:GENE – Get Free Report) was the recipient of a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 8,100 shares, a decline of 44.5% from the August 15th total of 14,600 shares. Based on an average trading volume of 47,100 shares, the days-to-cover ratio is currently 0.2 days.
Genetic Technologies Stock Down 2.5 %
NASDAQ GENE traded down $0.02 on Friday, reaching $0.80. 20,057 shares of the company were exchanged, compared to its average volume of 45,187. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.55 and a current ratio of 1.67. The business’s fifty day moving average price is $0.87 and its 200 day moving average price is $1.80. Genetic Technologies has a fifty-two week low of $0.69 and a fifty-two week high of $4.65.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Genetic Technologies stock. Armistice Capital LLC acquired a new position in Genetic Technologies Limited (NASDAQ:GENE – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 140,000 shares of the biotechnology company’s stock, valued at approximately $210,000. Armistice Capital LLC owned 3.18% of Genetic Technologies as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 0.63% of the company’s stock.
Genetic Technologies Company Profile
Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates through AffinityDNA, EasyDNA, and GeneType/Corporate segments.
Recommended Stories
- Five stocks we like better than Genetic Technologies
- Health Care Stocks Explained: Why You Might Want to Invest
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- How to Calculate Return on Investment (ROI)
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for Genetic Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genetic Technologies and related companies with MarketBeat.com's FREE daily email newsletter.